Société de Therapeutique Marocaine S.A. (CBSE:SOT)

Market Cap	12.81B
Revenue (ttm)	3.04B
Net Income (ttm)	345.28M
Shares Out	7.20M
EPS (ttm)	47.96
PE Ratio	37.76
Forward PE	34.15
Dividend	28.00 (1.57%)
Ex-Dividend Date	Jun 20, 2025

Volume	162
Average Volume	61
Open	1,755.00
Previous Close	1,750.00
Day's Range	1,750.00 - 1,787.00
52-Week Range	906.00 - 1,950.00
Beta	-0.03
RSI	48.60
Earnings Date	Jul 31, 2025

About CBSE:SOT

Société de Therapeutique Marocaine S.A., a pharmaceutical company, engages in the manufacturing of licensed medicines in Morocco. It offers products in various therapeutic areas, such as allergology, oncology, cardiology, dental, dermatology, endocrinology, gastroenterology, gynecology, ophthalmology, ENT, pediatric, pulmonology, reanimation, rheumatology, central nervous system (CNS), and urology, as well as antibiotics and generics. The company also provides its products in various forms, including tablets, capsules, pouches, syrups, suspensi...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 1,316
• Stock Exchange: Casablanca Stock Exchange
• Ticker Symbol: SOT

Financial Performance

In 2024, CBSE:SOT's revenue was 2.82 billion, an increase of 13.27% compared to the previous year's 2.49 billion. Earnings were 315.29 million, an increase of 19.99%.